RecruitingNot ApplicableNCT06664827

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

Outcomes of Blood Flow Restriction Training on the Ulnar Collateral Ligament


Sponsor

The Methodist Hospital Research Institute

Enrollment

50 participants

Start Date

Jan 16, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are: 1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR? Participants will: * Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.


Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria3

  • Healthy volunteer
  • Agree to complete all exercise sessions and program in its entirety
  • Between the ages of 18-50 years old

Exclusion Criteria9

  • Current or recent injury of the hand, elbow, or shoulder
  • Outside of the ages of 18-50 years old
  • Vascular compromise or previous vascular surgery
  • History of DVT
  • Current participation in other BFR research study
  • Currently participating in a structured strength training program
  • Any musculoskeletal conditions resulting in inability to exercise
  • Participants may not be collegiate/professional baseball/softball players
  • Vulnerable populations

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDelfi PTS Blood Flow Restriction Tourniquet System

In Houston Methodist rehabilitation clinics these devices are used as standard of care for BFR therapy in many post-operative treatments. General guidelines suggest using ranges between 30% - 80% of limb occlusion pressure (LOP). In our previous research efforts involving BFR the investigators have adhered to these guidelines and experienced no adverse events while observing these ranges to be well tolerated by subjects.


Locations(1)

Houston Methodist Hospital

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06664827


Related Trials